Magenta Therapeutics appoints Jason Ryan as COO, CFO

World |  News | 0 Comment | 20 Nov, 2018

US based clinical-stage biotechnology company Magenta Therapeutics has announced that it has strengthened its executive ...Read more

WHO and partners launch new country-led response for Malaria

World |  News | 0 Comment | 20 Nov, 2018

In order to scale up prevention and treatment, and increased investment, to protect vulnerable people from Malaria, WHO ...Read more

Michel Orsinger joins LimaCorporate's Advisory Board

World |  News | 0 Comment | 20 Nov, 2018

LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will ass...Read more

Sandoz, Pear Therapeutics announce launch of reSET

World |  News | 0 Comment | 20 Nov, 2018

Sandoz, a Novartis division, and Pear Therapeutics, Inc., has announced the commercial launch of reSET for patients with...Read more

Merck, Pfizer give information of Avelumab in Refractory Ovarian Cancer

World |  News | 0 Comment | 20 Nov, 2018

Merck and Pfizer Inc. announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combinatio...Read more

Forbion leads €40M Series B financing in Inflazome

World |  News | 0 Comment | 20 Nov, 2018

Forbion, a leading European life science venture capital firm has announced that it has led a Series B financing round o...Read more

WHO to shift focus on eliminating Chagas disease

World |  News | 0 Comment | 19 Nov, 2018

The World Health Organization (WHO) is shifting its focus towards active screening of girls and women of childbearing ag...Read more

Agilent expands cell analysis facility in Ireland

World |  News | 0 Comment | 19 Nov, 2018

Agilent Technologies Inc. has announced the opening of a new, purpose-built extension to its Little Island, Cork facilit...Read more

Mission Therapeutics team up with AbbVie against Alzheimer's, Parkinson’s

World |  News | 0 Comment | 16 Nov, 2018

Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes...Read more

Vyera to Initiate Phase 1 Study of NCE for Toxoplasmosis

World |  News | 0 Comment | 16 Nov, 2018

Vyera Pharmaceuticals, LLC  has announced that it plans to initiate a Phase 1 single ascending dose (SAD) study of ...Read more

FDA ratcheting up pressure on flavored tobacco and e-cig products

World |  News | 0 Comment | 16 Nov, 2018

Singapore - Citing the sharp rise in youth use of e-cigarettes, FDA Commissioner Scott Gottlieb, M.D. announces&nbs...Read more

Boston Scientific to restructure in 2019

World |  News | 0 Comment | 16 Nov, 2018

Singapore - Aimed at trimming annual operating expenses by $100M - 150M and boosting performance, Boston Scientific will...Read more

ADC Bio secures additional equity round investment

World |  News | 0 Comment | 15 Nov, 2018

ADC Biotechnology (ADC Bio), announces that it has secured additional funding of £2.5 million from existing invest...Read more

Exscientia acquires Kinetic Discovery to build 'full stack' AI-driven drug discovery capabilities

World |  News | 0 Comment | 15 Nov, 2018

Singapore - Exscientia, the company leading the use of Artificial Intelligence (AI) in drug discovery, announces that is...Read more

J&J cleared of liability in talc cancer case by California jury

World |  News | 0 Comment | 15 Nov, 2018

Singapore - A California jury clears Johnson & Johnson of liability in a case involving a woman who alleged tha...Read more

Nashville Biosciences enters into agreement with BC Platforms

World |  News | 0 Comment | 15 Nov, 2018

Singapore - BC Platforms, a world leader in secure genomic data management and analytics, announces an agreement with Na...Read more

Sandoz to focus on more lucrative markets

World |  News | 0 Comment | 15 Nov, 2018

Novartis’ Sandoz division recently announced that it was no longer pursuing US approval for Rixathon, its biosimil...Read more

Grunenthal establishes commercial footprint in the US

World |  News | 0 Comment | 14 Nov, 2018

Grunenthal has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint ...Read more